98%
921
2 minutes
20
Purpose Of Review: This review aims to raise awareness of the Allergic Rhinitis and its Impact on Asthma (ARIA) and European Forum for Research and Education in Allergy and Airway Disease (EUFOREA) guidelines for allergic rhinitis (AR) by presenting a side-by-side summary of their key elements. Drawing on the authors' direct involvement in the development of both, it highlights their evolution toward precision medicine and patient-centred care to support stronger doctor-patient partnerships.
Recent Findings: Both ARIA and EUFOREA offer evidence-based guidance to support AR management, with increasing emphasis on personalisation and digital integration. While aligned in goals, they differ in patient classification, treatment delivery, and implementation strategies. Barriers to real-world use include the need for contextual adaptation, targeted education for healthcare providers and patients, and inconsistent alignment between guideline-based prescriptions and patient behaviour. Mobile health (mHealth) tools offer valuable support but require sustained engagement. Greater awareness of these guidelines can improve implementation, harmonise treatment approaches, and ultimately enhance care delivery and outcomes for individuals with AR.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s11882-025-01212-x | DOI Listing |
Allergol Immunopathol (Madr)
September 2025
Quirón Dexeus University Hospital, Nevot Casas Paediatric and Family Clinic, Calle Sabino Arana, Barcelona, Spain.
is an ubiquitous mold commonly found in both outdoor and indoor environments. It is a common airborne mold recognized as a significant aeroallergen linked to pediatric allergic rhinitis and asthma. Although sensitization rates in children vary regionally, evidence suggests that allergy significantly impacts pediatric respiratory health and as its exposure worsens, respiratory outcomes in susceptible pediatric populations .
View Article and Find Full Text PDFAllergol Immunopathol (Madr)
September 2025
Department of Pulmonary Medicine, Rajasthan Hospital, Jaipur, India.
Saline nasal irrigation provides symptom relief in allergic rhinitis (AR), but the optimal saline concentration remains uncertain. The comparative efficacy of 3% hypertonic saline nasal irrigation (HSNI) versus 0.9% isotonic saline is still debated.
View Article and Find Full Text PDFAllergol Immunopathol (Madr)
September 2025
Department of Clinic of Chest Diseases, Samsun Education and Research Hospital, Samsun, Turkey.
Background: Allergic rhinitis and allergic asthma are respiratory tract diseases predominantly triggered by allergens such as pollens, house dust mite, mold etc. The prevalence of respiratory allergens varies according to geographic location. Ragweed (), a prevalent weed particularly in South America and Europe, is being investigated for its sensitization frequency in the Black Sea region of our country.
View Article and Find Full Text PDFJ Dermatol
September 2025
Sanofi K.K., Shinjuku, Tokyo, Japan.
Chronic spontaneous urticaria (CSU) affects 0.5%-1.0% of the population worldwide.
View Article and Find Full Text PDFChin J Integr Med
September 2025
Department of Pulmonary and Critical Care Medicine/Department of Integrated Traditional Chinese and Western Medicine for Pulmonary Diseases Part 1, National Center for Integrative Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital; National Center for Respiratory Medicine; Ins
Objective: To observe the clinical effect and safety of Lu'e Biyan Formula (LBF) combined with loratadine in the treatment of moderate to severe allergic rhinitis (AR) patients with Fei (Lung)-qi deficiency-coldness (FQDC) syndrome.
Methods: From September 2023 to December 2024, moderate to severe AR patients with FQDC syndrome were recruited from the Outpatient Department of Integrated Traditional Chinese and Western Medicine for Pulmonary Diseases Part 1, China-Japan Friendship Hospital. Participants were randomly assigned to a test group and a control group by using a random number table at a ratio of 1:1.